BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Celaid and AGC Partner in Japan to Advance Scalable Expansion of iPSC-Derived Blood Stem Cells

Celaid Therapeutics Inc. ("Celaid") have executed a collaborative research agreement with AGC Inc. ("AGC") to advance iPS cell-derived hematopoietic stem a...

August 29, 2025 | News

Cold Chain Technologies accelerates APAC expansion with new hubs, distributors, and manufacturing site

Cold Chain Technologies (CCT), has reinforced its commitment to expanding its Asia Pacific (APAC) presence with a series of investments and partnerships. ...

August 28, 2025 | News

Fujitsu Unveils Secure AI Agent Platform To Transform Healthcare Operations In Japan

Fujitsu announced the development of a secure and efficient AI agent platform to accelerate operational efficiency and ensure stable medical service provis...

August 28, 2025 | News

Otsuka Medical Devices Receives Japan Approval For Paradise Ultrasound Renal Denervation System To Treat Resistant Hypertension

Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) announced that the Paradise™ Ultrasound Renal Denervation (uRDN) system has r...

August 26, 2025 | News

Transforming Cancer Care in Japan and Asia-Pacific: Thermo Fisher’s Jane Li on Accelerating Precision Oncology with Next-Gen Diagnostics

BioPharma APAC spoke with Jane Li, Senior Director, Pharma CDx and CRO Partnership at Thermo Fisher Scientific, about the development of the Oncomine&trade...

August 25, 2025 | Expert Insight

Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025

The first eight months of 2025 have been transformative for biosupplier technologies worldwide. From innovative lab reagents and biomaterials to ad...

August 22, 2025 | Analysis

Japan’s ARC Therapies Initiates Research on Novel Gut Microbe YB328 for Cancer Immunotherapy

ARC Therapies Inc. (Head Office: Shinjuku, Tokyo; President & CEO: Rami Suzuki), a certified startup from the National Cancer Cente...

August 21, 2025 | News

Astria Licenses HAE Drug Navenibart to Japan’s Kaken in $32M+ Deal

-- Up to $32 Million in Upfront and Milestone Payments, Plus Royalties -- -- Kaken Expertise in Commercializing Innovative Therapies Supports Navenibart...

August 08, 2025 | News

Asahi Kasei to Build New Planova™ Virus Filter Plant in Japan to Meet Surging Biopharma Demand

Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova&trad...

July 31, 2025 | News

Tigermed Acquires Japan’s First Imaging CRO Micron to Bolster Asia-Pacific Medical Imaging Capabilities

Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, annou...

July 30, 2025 | News

Revival Healthcare Capital and Olympus Launch $458M Joint Venture to Advance GI Robotics Innovation

Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships in MedTech is, pleased to announce a st...

July 28, 2025 | News

GHIT Fund Commits JPY 1 Billion to Combat Malaria and Tuberculosis Through Global R&D Partnerships

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1 billion (USD 7.3 million1) in ...

July 17, 2025 | News

Japanese Life Sciences Delegation Strengthens Collaboration with North Carolina’s Innovation Ecosystem

A high-level Japanese delegation specializing in life sciences concluded a three-day visit to North Carolina (June 24–26), further strengthening ties...

July 07, 2025 | News

AvenCell Secures Up to $40 Million AMED Grant to Advance Dual-Antigen Allogeneic CAR-T Therapy

AvenCell Japan, a wholly owned subsidiary of AvenCell Therapeutics, a private, clinical-stage biotechnology company developing best-in-class CAR-T therapie...

July 02, 2025 | News

Stay Connected